Sort
50,496 grants matching “lung cancer”
Excellence in Research: Design and Synthesis of Nanoscale-Metal Organic Frameworks for Targeted Prostate Cancer Therapy
$518,840Karl T Jackson · Virginia State University · · FY2024 · MPS
Systemic RNA Delivery to Tumors
$518,820Jinjun Shi · Brigham And Women'S Hospital · R01 · FY2024 · CA
RRM1/PTEN Axis in Non-Small Cell Lung Cancer
$518,744H. Lee Moffitt Cancer Ctr &Res Inst · R01 · FY2003 · CA
Validation of findings from the Epigenome-Wide Association Study of Breast Cancer
$518,726Susan R Sturgeon · University Of Massachusetts Amherst · U01 · FY2014 · CA
Lung Cancer Chemoradiation: Predictors of Survival
$518,680Xifeng Wu · University Of Tx Md Anderson Can Ctr · R01 · FY2006 · CA
AUTOMATED CLOSED SYSTEM FOR DMSO REMOVAL FROM PERIPHERAL BLOOD STEM CELLS
$518,616Erik J Woods · General Biotechnology, Llc · R44 · FY2007 · HL
Prevention Research Educational Postdoctoral (PREP) Training Program
$518,608Julia H Rose · Case Western Reserve University · R25 · FY2007 · CA
New Chemical Methods for Molecular Imaging to Impact Clinical Care
$518,586Tobias Ritter · Harvard University · R01 · FY2014 · EB
Molecular Landscape-based Innovative Therapies for Anaplastic Thyroid Carcinoma
$518,583Antonio Di Cristofano · Sloan-Kettering Inst Can Research · P50 · FY2016 · CA
REGULATION OF MUCOUS CELL METAPLASIA IN ASTHMA
$518,500Yohannes Tesfaigzi · Lovelace Biomedical & Environmental Research Institute · R01 · FY2008 · HL
The Boston University-UCLA Lung Cancer Biomarker Development Lab
$518,499Marc Elliott Lenburg · Boston University Medical Campus · U01 · FY2018 · CA
Defining Mechanisms of Pathological Trans-Lesion Synthesis During Carcinogenesis
$518,457Cyrus Vaziri · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA
Defining Mechanisms of Pathological Trans-Lesion Synthesis During Carcinogenesis
$518,457Cyrus Vaziri · Univ Of North Carolina Chapel Hill · R01 · FY2020 · CA
Mutant Surfactant - Induced TGF-beta Secretion in Lung Fibrosis
$518,426Christine Kim Garcia · Ut Southwestern Medical Center · R01 · FY2015 · HL
Lung Cancer Chemoradiation: Predictors of Survival
$518,356Xifeng Wu · University Of Tx Md Anderson Can Ctr · R01 · FY2007 · CA
Selective Inhibitors of T Cell Activation Target Exportin-1 at Cys528 to Suppress Pathological T Cell Activation
$518,271Drew James Adams · Case Western Reserve University · R01 · FY2024 · AI
Estimating Overdiagnosis in Cancer Screening Studies
$518,246Ruth D Etzioni · Fred Hutchinson Cancer Research Center · R01 · FY2015 · CA
Shape Control and Transport Properties of DNA-Copolymer Micelles
$518,239Hai-Quan Mao · Johns Hopkins University · R01 · FY2016 · EB
Modulation of lung immunity by CoronaVirus
$518,190Anna Karolina Palucka · Jackson Laboratory · U19 · FY2020 · AI
Functional role of the MUC1-C oncoprotein in non-small cell lung cancer
$518,175Donald W. Kufe · Dana-Farber Cancer Inst · R01 · FY2014 · CA
(PQ3) The role of damaged DNA in inter-individual variation of tumor immunity
$518,165Nir Hacohen · Broad Institute, Inc. · R01 · FY2020 · CA
(PQ3) The role of damaged DNA in inter-individual variation of tumor immunity
$518,165Nir Hacohen · Broad Institute, Inc. · R01 · FY2017 · CA
(PQ3) The role of damaged DNA in inter-individual variation of tumor immunity
$518,165Nir Hacohen · Broad Institute, Inc. · R01 · FY2016 · CA
(PQ3) The role of damaged DNA in inter-individual variation of tumor immunity
$518,165Nir Hacohen · Broad Institute, Inc. · R01 · FY2018 · CA
The Brooklyn Minority-Based Community Clinical Oncology Program
$518,164William Barney Solomon · Suny Downstate Medical Center · U10 · FY2011 · CA